| For: | Mu F, Hu LS, Xu K, Zhao Z, Yang BC, Wang YM, Guo K, Shi JH, Lv Y, Wang B. Perioperative remedial antiviral therapy in hepatitis B virus-related hepatocellular carcinoma resection: How to achieve a better outcome. World J Gastrointest Oncol 2024; 16(5): 1833-1848 [PMID: 38764825 DOI: 10.4251/wjgo.v16.i5.1833] | 
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v16/i5/1833.htm | 
| Number | Citing Articles | 
| 1 | 
                             
                                            Vishal G Shelat. Improving clinical outcomes of patients with hepatocellular carcinoma: Role of antiviral therapy, conversion therapy, and palliative therapy. World Journal of Gastrointestinal Oncology 2024; 16(10): 4037-4041 doi: 10.4251/wjgo.v16.i10.4037
                                         
                                            
                                     | 
                    
| 2 | 
                             
                                            Hui Wan, Yu-Xin Zhang, Guan-Yue Shan, Jun-Ya Cheng, Duan-Rui Qiao, Yi-Ying Liu, Wen-Na Shi, Hai-Jun Li. Antiviral therapy for hepatitis B virus infection is beneficial for the prognosis hepatocellular carcinoma. World Journal of Gastrointestinal Oncology 2025; 17(1): 93983 doi: 10.4251/wjgo.v17.i1.93983
                                         
                                            
                                     | 
                    
